Alexandria® — the world’s largest body of medical evidence for clinical decision support and LLM training.

Read the release
Learn more
Logo
  • Solutions
        • Health Systems
          • Pharmacy
          • Research Informatics
          • Value Based Care / Quality
          • GME
        • Life Sciences
          • Precision Medicine AI/ML
          • HEOR, Medical Affairs & RWE
          • Research & Development
          • Commercial Analytics
  • Technology
        • Content
          • Alexandria®
        • Automation Solutions
          • Atropos Evidence™ Agent
          • ChatRWD®
          • Green Button®
          • Forge®
        • Data
          • GENEVA OS®
          • Atropos Evidence™ Network
          • Data Quality Scoring
  • About
    • About Us
    • Careers
  • Resources
    • Resource Center
    • Publications
    • Customer Stories
    • News & Media
    • Press Releases
    • Blog
  • Contact Us
  • Login
Race and Ethnicity on Diagnosis, Metastasis, and Mortality of Soft Tissue Sarcomas in Retrospective Cohort Study

Race and Ethnicity on Diagnosis, Metastasis, and Mortality of Soft Tissue Sarcomas in Retrospective Cohort Study

by Julia Rudo | Nov 14, 2024 | Publications

An abstract titled, “Race and Ethnicity on Diagnosis, Metastasis, and Mortality of Soft Tissue Sarcomas in Retrospective Cohort Study,” was presented at the Connective Tissue Oncology Society (CTOS) 2024 Annual Meeting by authors Ellen Zhang, William Pike, Gavin Hui,...
Specialists discuss concerns over impact of semaglutide on the eye

Specialists discuss concerns over impact of semaglutide on the eye

by Julia Rudo | Nov 8, 2024 | News and Media

“In a letter to the editor published in the Journal of Diabetes Science and Technology, David C. Klonoff, MD, medical director of the Diabetes Research Institute at Mills-Peninsula Medical Center in San Mateo, California, noted that the findings of the Hathaway...
Inflammatory vaginitis in women with multiple sclerosis: a retrospective analysis of B-cell depleting therapy

Inflammatory vaginitis in women with multiple sclerosis: a retrospective analysis of B-cell depleting therapy

by Joy Somogyi | Oct 25, 2024 | Publications

A new paper titled “Inflammatory vaginitis in women with multiple sclerosis: a retrospective analysis of B-cell depleting therapy compared to other disease modifying therapies” was published in Multiple Sclerosis and Related Disorders by authors Sarah...
HLTH24: Atropos Health unveils chat-based AI co-pilot for real-world evidence

HLTH24: Atropos Health unveils chat-based AI co-pilot for real-world evidence

by Julia Rudo | Oct 23, 2024 | News and Media

“Atropos Health’s large language model for real-world evidence is now ready for prime time after a successful beta program. The startup, maker of a real-world data (RWD) platform, announced this week that ChatRWD®, a generative artificial intelligence (AI)...
ChatRWD™ Exceeds Expectations in Beta and now Available to Clinicians and Researchers

ChatRWD™ Exceeds Expectations in Beta and now Available to Clinicians and Researchers

by Joy Somogyi | Oct 22, 2024 | Press Release

Overwhelmingly Positive Performance and Results from Beta Users Accelerate Product Availability to Additional Users PALO ALTO, Calif. – October 22, 2024 – Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world...
« Older Entries
Next Entries »
DiviWP Logo
  • Follow
  • Follow

Solutions

Health Systems

Pharmacy

Research Informatics

Value Based Care / Quality

GME

Life Sciences

Precision Medicine AI/ML

HEOR, Medical Affairs & RWE

Research & Development

Commercial Analytics

Technology

Content

Alexandria®

Automation Solutions

Atropos Evidence™ Agent

ChatRWD®

Green Button®

Forge®

Data

GENEVA OS®

Atropos Evidence™ Network

Data Quality Scoring

About

  • About Us
  • Careers

Resources

  • Resources Center
  • Publications
  • Customer Stories
  • News & Media
  • Press Releases
  • Blog

Copyright © 2026 Atropos Health. All Rights Reserved | Privacy Policy | Ethics Report | Terms of Service

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}